We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETRN
1351
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $519K | ﹤0.01% |
23,807
-2,012
| -8% | -$40.3K |
|
|
SIX
1352
DELISTED
Six Flags Entertainment Corp.
SIX
| $519K | ﹤0.01% |
10,510
+3,333
| +46% | +$188K |
|
1353
Cass Information Systems
CASS
$676M
| $518K | ﹤0.01% |
10,955
+2,298
| +27% | +$118K |
|
|
LL
1354
DELISTED
LL Flooring Holdings, Inc.
LL
| $517K | ﹤0.01% |
51,201
-1,868
| -4% | -$20.7K |
|
1355
First Horizon
FHN
$12.2B
| $516K | ﹤0.01% |
36,909
-2,055
| -5% | -$30.4K |
|
1356
Ichor Holdings
ICHR
$3.32B
| $516K | ﹤0.01% |
22,870
-3,362
| -13% | -$68.5K |
|
|
NXRT
1357
NexPoint Residential Trust
NXRT
$664M
| $515K | ﹤0.01% |
13,434
+2,185
| +19% | +$80.3K |
|
1358
Central Garden & Pet Co Class A
CENTA
$2.39B
| $514K | ﹤0.01% |
27,626
+4,455
| +19% | +$107K |
|
1359
Quanex
NX
$848M
| $513K | ﹤0.01% |
32,294
-635
| -2% | -$10.1K |
|
1360
Phibro Animal Health
PAHC
$1.37B
| $512K | ﹤0.01% |
15,507
+2,660
| +21% | +$82.8K |
|
1361
EXL Service
EXLS
$4.1B
| $511K | ﹤0.01% |
42,600
+3,710
| +10% | +$43.5K |
|
1362
Oceaneering
OII
$4.49B
| $510K | ﹤0.01% |
32,346
+1,132
| +4% | +$17.5K |
|
1363
Norwegian Cruise Line
NCLH
$8.87B
| $509K | ﹤0.01% |
9,265
-6,080
| -40% | -$313K |
|
|
1364
Central Garden & Pet Co
CENT
$2.74B
| $508K | ﹤0.01% |
24,833
+3,958
| +19% | +$106K |
|
1365
Essential Utilities
WTRG
$11.2B
| $507K | ﹤0.01% |
13,900
+6,505
| +88% | +$229K |
|
1366
Cavco Industries
CVCO
$4.39B
| $505K | ﹤0.01% |
4,299
+803
| +23% | +$110K |
|
|
QEP
1367
DELISTED
QEP RESOURCES, INC.
QEP
| $501K | ﹤0.01% |
64,365
-23,081
| -26% | -$184K |
|
1368
Buckle
BKE
$2.23B
| $499K | ﹤0.01% |
26,658
+2,444
| +10% | +$44.7K |
|
1369
Methode Electronics
MEI
$583M
| $499K | ﹤0.01% |
17,347
-3,541
| -17% | -$96.6K |
|
1370
Nasdaq
NDAQ
$51.4B
| $497K | ﹤0.01% |
17,049
-657,345
| -97% | -$18.7M |
|
|
MPT
1371
Medical Properties Trust
MPT
$2.88B
| $494K | ﹤0.01% |
26,677
-43,233
| -62% | -$771K |
|
|
TUP
1372
DELISTED
Tupperware Brands Corporation
TUP
| $494K | ﹤0.01% |
19,308
+4,973
| +35% | +$152K |
|
1373
Myriad Genetics
MYGN
$535M
| $493K | ﹤0.01% |
14,859
+2,034
| +16% | +$61.9K |
|
1374
Tapestry
TPR
$29B
| $493K | ﹤0.01% |
15,186
-6,684
| -31% | -$234K |
|
1375
John B. Sanfilippo & Son
JBSS
$939M
| $492K | ﹤0.01% |
6,846
-413
| -6% | -$27.6K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.